Home » Stocks » CryoPort

CryoPort, Inc. (CYRX)

Stock Price: $33.09 USD -1.89 (-5.40%)
Updated Aug 7, 2020 11:27 AM EDT - Market open

Stock Price Chart

Key Info

Market Cap 1.26B
Revenue (ttm) 37.06M
Net Income (ttm) -19.89M
Shares Out 38.11M
EPS (ttm) -0.57
PE Ratio n/a
Forward PE 277.78
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $33.09
Previous Close $34.98
Change ($) -1.89
Change (%) -5.40%
Day's Open 32.74
Day's Range 32.01 - 33.87
Day's Volume 386,424
52-Week Range 12.40 - 36.78

More Stats

Market Cap 1.26B
Enterprise Value 1.17B
Earnings Date (est) Nov 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 38.11M
Float 37.58M
EPS (basic) -0.55
EPS (diluted) -0.57
FCF / Share -0.13
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 9.49M
Short Ratio 14.66
Short % of Float 27.27%
Beta 0.91
PE Ratio n/a
Forward PE 277.78
P/FCF Ratio n/a
PS Ratio 34.02
PB Ratio 9.70
Revenue 37.06M
Operating Income -19.12M
Net Income -19.89M
Free Cash Flow -4.89M
Net Cash 91.31M
Net Cash / Share 2.40
Gross Margin 46.82%
Operating Margin -51.59%
Profit Margin -53.70%
FCF Margin -13.18%
ROA -11.79%
ROE -23.93%
ROIC -26.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (6)

Buy 6
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$31.83*
(-3.81% downside)
Low
23.0
Current: $33.09
High
40.0
Target: 31.83
*Average 12-month price target from 6 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201420132012201120102009
Revenue33.9419.6311.957.683.942.661.100.560.480.12
Revenue Growth72.94%64.18%55.68%95.13%47.95%141.69%98.07%16.85%303.12%-
Gross Profit17.3510.245.973.101.170.44-0.49-0.84-0.83-0.60
Operating Income-17.68-8.64-7.89-8.77-5.59-5.08-6.32-7.43-5.60-4.20
Net Income-18.33-9.56-7.90-13.11-7.03-19.57-6.38-7.83-6.15-5.65
Shares Outstanding33.3928.2122.9614.225.014.073.152.411.110.42
Earnings Per Share-0.55-0.34-0.34-0.93-2.44-4.81-2.04-3.24-5.52-13.56
Operating Cash Flow-1.32-3.35-3.58-5.72-4.13-4.38-4.79-6.78-4.81-2.85
Capital Expenditures-5.34-2.91-1.71-1.06-0.07-0.14-0.16-0.26-0.34-0.03
Free Cash Flow-6.66-6.27-5.30-6.78-4.20-4.52-4.94-7.04-5.15-2.89
Cash & Equivalents94.7347.6115.414.891.410.370.564.879.373.72
Total Debt4.8014.77-0.651.542.982.721.814.024.22
Net Cash / Debt89.9332.8415.414.24-0.13-2.61-2.163.065.35-0.50
Assets13656.6220.268.112.611.711.766.2111.034.78
Liabilities9.5918.072.382.433.024.013.822.485.085.69
Book Value12638.5517.895.68-0.42-2.30-2.063.735.95-0.91
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name CryoPort, Inc.
Country United States
Employees 105
CEO Jerrell W. Shelton

Stock Information

Ticker Symbol CYRX
Stock Exchange NASDAQ
Sector Industrials
Industry Integrated Freight & Logistics
Unique Identifier NASDAQ: CYRX

Description

Cryoport, Inc. provides temperature-controlled logistics and biostorage services to the life sciences industry in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Global Logistics Solutions and Global Bioservices. The Global Logistics Solutions segment offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, a dry vapor cryogenic shipper that use liquid nitrogen contained inside a vacuum insulated vessel, which serves as a refrigerant to provide stable storage temperatures. This segment also provides Cryoport Express Advanced Therapy Shippers, which offer verification information and supply chain support for biopharma companies; and Cryoport Express C3 Shippers, a non-cryogenic temperature-controlled shipper designed to maintain a controlled temperature. In addition, it offers Cryoport Express SmartPak II Condition Monitoring System to track the key aspects and condition of each shipment; and Cryoport Express Analytics to track the time-based metrics for order processing time and on-time deliveries, as well as profiling shipping lanes to determine average transit times and predicting shipping exceptions based on historical metric. The Global Bioservices segment provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens. The company also offers logistics support and management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.